Mesenchymal stem cells added to second-line therapy improve response and failure-free survival in steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A meta-analysis of randomized controlled trials

BackgroundSteroid-refractory acute graft-versus-host disease (aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT), with limited effective treatment options. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic...

Descrición completa

Detalles Bibliográficos

Principais autores:	Man Xiao, Yinghu Yan, Rui Zhang, Dan Wang, Li Wang, Yameng Zhao, Jinhong Yang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-11-01
Series:	Frontiers in Oncology
Assuntos:	mesenchymal stem cells steroid-refractory acute graft-versus-host disease hematopoietic stem cell transplantation meta-analysis randomized controlled trial
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1704963/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!